These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
221 related articles for article (PubMed ID: 15630913)
1. Lessons on prescribing and drug safety from the withdrawal of rofecoxib. Nelson M; Cicuttini F Aust Fam Physician; 2004 Dec; 33(12):965-6. PubMed ID: 15630913 [No Abstract] [Full Text] [Related]
2. The lessons of Vioxx. Frazier KC N Engl J Med; 2005 Sep; 353(13):1420-1; author reply 1420-1. PubMed ID: 16192497 [No Abstract] [Full Text] [Related]
3. The Vioxx debacle revisited. Mohapatra PR; Janmeja AK Am J Med; 2005 Sep; 118(9):1058. PubMed ID: 16164909 [No Abstract] [Full Text] [Related]
4. Cyclooxygenase-2 inhibitors and cardiovascular risk. Smith ER Can J Cardiol; 2005 Mar; 21(3):307-8. PubMed ID: 15776124 [No Abstract] [Full Text] [Related]
5. The withdrawal of rofecoxib. Arellano FM Pharmacoepidemiol Drug Saf; 2005 Mar; 14(3):213-7. PubMed ID: 15724267 [No Abstract] [Full Text] [Related]
6. The Vioxx debacle revisited. Good CB; Kelley CL Am J Med; 2005 Sep; 118(9):1055-6; author reply 1056-7. PubMed ID: 16164902 [No Abstract] [Full Text] [Related]
7. How to avoid another 'Vioxx'. Frantz S Nat Rev Drug Discov; 2005 Jan; 4(1):5-7. PubMed ID: 15690595 [No Abstract] [Full Text] [Related]
8. Adverse oral reactions associated with the COX-2 inhibitor rofecoxib. Bagán JV; Thongprasom K; Scully C Oral Dis; 2004 Nov; 10(6):401-3. PubMed ID: 15533219 [TBL] [Abstract][Full Text] [Related]
9. The great rofecoxib feeding frenzy. Van Way CW JPEN J Parenter Enteral Nutr; 2005; 29(2):136-8. PubMed ID: 15772394 [No Abstract] [Full Text] [Related]
10. [Withdrawal of rofecoxib: a sign to be careful with coxibs in patients with increased cardiovascular risk]. Bijlsma JW Ned Tijdschr Geneeskd; 2004 Oct; 148(44):2162-4. PubMed ID: 15559407 [TBL] [Abstract][Full Text] [Related]
11. Intracranial hypertension induced by rofecoxib. Jacob S; Rajabally YA Headache; 2005 Jan; 45(1):75-6. PubMed ID: 15663617 [TBL] [Abstract][Full Text] [Related]
12. The lessons of Vioxx--drug safety and sales. Waxman HA N Engl J Med; 2005 Jun; 352(25):2576-8. PubMed ID: 15972862 [No Abstract] [Full Text] [Related]
13. Lessons from the withdrawal of rofecoxib. Dieppe PA; Ebrahim S; Martin RM; Jüni P BMJ; 2004 Oct; 329(7471):867-8. PubMed ID: 15485938 [TBL] [Abstract][Full Text] [Related]